Department of Medicine, Baylor College of Medicine, Houston, TX, USA.
Nephrol Dial Transplant. 2010 Aug;25(8):2795-8. doi: 10.1093/ndt/gfq265. Epub 2010 May 19.
Pulmonary alveolar proteinosis (PAP) has been associated with the immunosuppressant sirolimus in transplant patients. PAP is a progressive lung disease characterized by the accumulation of surfactant-like material in the lungs leading to decreased pulmonary function with shortness of breath and cough as common symptoms. We report a rare case of sirolimus-associated PAP in a kidney transplant recipient with a history of end-stage renal disease secondary to haemolytic uraemic syndrome (HUS) and review of the literature. Discontinuation of sirolimus and initiation of tacrolimus led to resolution of PAP without recurrence of HUS.
肺肺泡蛋白沉积症(PAP)与移植患者中的免疫抑制剂西罗莫司有关。PAP 是一种进行性肺部疾病,其特征是肺中表面活性剂样物质的积累,导致呼吸急促和咳嗽等常见症状的肺功能下降。我们报告了一例肾移植受者中罕见的西罗莫司相关 PAP 病例,该患者继发于溶血尿毒综合征(HUS)的终末期肾病病史,并对文献进行了回顾。停用西罗莫司并开始使用他克莫司导致 PAP 消退,而 HUS 未再复发。